and transient hemolytic anemia responsive to tuberculosis chemotherapy without the use of corticosteroids. Both transfusions and anti-tuberculosis drugs are known to cause hemolytic anemia, but, in this case, the hemolysis preceded all interventions. Adults with transient hemolytic anemia secondary to tuberculosis demonstrate a self-limited hemolysis that is responsive to RIPE without corticosteroids. [3] [4] [5] [6] [7] Children, however, tend to demonstrate a more severe symptomatology that may benefit from corticosteroids. In India, a case was reported of disseminated tuberculosis and hemolytic anemia (Hb 1.8 g/dL) in an 8-year-old girl. This patient required transfusions and corticosteroids, but showed clinical improvement only after the start of anti-tuberculosis drugs. 8 Gupta et al. reported intestinal tuberculosis and hemolytic anemia (Hb 6 g/dL) in an 8-year-old Indian boy who also received corticosteroids but improved only after initiating anti-tuberculosis therapy. 9 Normalization of the hematologic parameters only with anti-tuberculosis therapy is proof that tuberculosis should be listed among the infectious causes of hemolytic anemia. Hemolytic anemia can be a fatal complication and, in severe cases, the use of corticosteroids may be indicated but should be used judiciously. Tuberculosis being a common disease, the association with transient hemolytic anemia should be recognized and treated appropriately.
